Whom to Treat for Primary Prevention of Atherosclerotic Ca | UPDATES IN MEDICINE
Whom to Treat for Primary Prevention of Atherosclerotic Cardiovascular Disease
● USPSTF Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease
The US Preventive Services Task Force (USPSTF) has released its updated 2022 recommendations, supported by an updated evidence report, to guide the use of low-dose aspirin for the primary prevention of atherosclerotic cardiovascular disease (ASCVD), changing the age ranges and recommendation grades and focusing on preventing ASCVD events.